Aggregators Using Other Jobsite Postings

I not sure you are all aware of the prevalence of the new model where companies aggregate job postings from other job boards to solicit resumes. Apparently not wanting to attempt to entice their own audience or to drive down costs, some job boards are merely a compilation of other sites that a job seeking can create an alert and have jobs sent to them. While it is an obvious cost savings for the aggregator and they may in fact be making money off the original posting (unsure at this point) in this writer's opinion they seem to have muddied the water. How does a job seeker really know who they are dealing with or if the actual job opening organization ever gets their application? With the amount of companies no longer acknowledging a candidates submission it may be an enormous waste of an applicants time and the benefits seem only to accrue to the aggregator. For an example check out Indeed.com.

That is why a legitimate recruiter using the sound industry method of searching out referrals via the telephone still is the most effective way to find and discuss career opportunities with passive high performing candidates.

If you calculate your time spend ferreting out the thousands of applicants from the multiple sources, maybe your money would be better spent firing your recruiting staff and let a professional help you save time, money and locate that candidate that will add to your bottom line.

Is decentralizing the key to sales team success?

"Remodeling Your Sales Force" an article by Christian Marcazzo in Pharmaceutical Executive Magazine suggests a less micro managed and decentralized sales force where the managers are seen more as CEOs of their region. Decentralizisation means for Christian, not doing "busy work" such as sales reports but rather letting managers manage (not headquarters) and setting clearer and precise goals. To read his article and to learn more about his suggestions and ways to implement them: Click Here.
Do you think this "model" works? Or do you think it could lead to problems of not enough motivation or accountability?

Love to hate Pharma? Most of America does...

So, what happened? In the last two years pharma's image has declined. With safety questions heightening people's fear of drugs, big pharma's has taken a public relations dumpster dive, despite their continual efforts to quell fears and help communities in need.

Another reason: "People don't want to be sick enough to take drugs." It already puts a negative image in their head.

To read more Click Here

What do you think big pharma should do to change this negative image?

Pharm Exec Magazine says: "Hey Sales Team, Let's DO SOMETHING!"

The article "Do Something" from Pharmaceutical Executive Magazine discusses 7 new steps to put your sales force on the right track. William Schieman number one piece of advice: have a sales strategy and stick to it. He also harps on the sales team's overall alignment with the company. This means sharing the beliefs of the company, and consistently acting as the ambassador for the company. In order to fix sales problem areas, he says to look for the root causes (which is much easier said than done.) His final words of wisdom are about keeping the best and loosing the rest. He argues for constant weeding out of the sales team, but making sure to have a system in place to keep the best, as well as hiring top performers. (We can help you with hiring the best!)

What steps do you think are missing?

Finding the Perfect Candidate

In our summer edition of our newsletter, we featured an interview with Cynthia Grant and an article by one of Lou Adler's colleagues. Now we want to know your opinion:


What attributes do you look for in the perfect candidate?
What is one of your deal makers?
How do you feel about the two articles, do you agree or disagree with some of the points made?
We look forward to hearing your response.


In addition, here is the link to the Bryan Johanson's article:
http://www.adlerconcepts.com/resources/column/newsletter/three_common_sense_secrets_to.php

News to Know: Lay Off = Rebounds (for some...)

Wall Street Journal Health Blog reports that despite the numerous lay offs, big pharma employees are finding jobs. The health bog states that: About 73% of the employees found jobs at the same or higher pay level, and 84% found work without having to relocate, the Newark Star-Ledger reports.

What do you think of these numbers? Are they indicative of a recovering industry or one in the process of restructuring?

FDA Says Safety First

Both the Wall Street Journal, their affiliated health blog and Pharm. Executive Magazine addresses the slowing down of drugs approved. Pharm. Executive Magazine tells us of the FDA's new policy, from labeling regulations and post marketing strategies. While, the Wall Street Journal's article gives a sweeping historical overview of the FDA's "swinging pendulum" between more lax or more conservative acceptance of drugs. Currently, with a more safety-oriented approach, the FDA is taking more precautions in approving drugs, some which have already been approved overseas. Due to Vioxx's severe side effects, FDA is weighing the potential side effects much more seriously. Last year, the FDA approved only 19 new drugs, the lowest number in 24 years. Despite this low number of drugs being approved, perhaps, doctors will feel more comfortable prescribing these drugs to their patients, leading to a greater financial success in the new drugs that do come to market.

So what does this mean for pharmaceutical companies?

Another restructuring, but this one focused on drug development and pipeline drugs. Some companies such as Schering-Plough are scrapping drugs before the expensive clinical trials begin, doubting the drug's approval by the FDA. Pharmaceutical companies will certainly be doing rigorous testing of whatever drug they look to approve. Yet, the article ends with the fact that some experimental new drugs that are being denied are costing people their health.
Tell us what you think.
Is the FDA's stringent approval policy a good thing?